Global ALS market expected to grow to $1.04bn in 2029 driven by anticipated drug launches
(WorldNews Japan)

28 Sep 2020 Global ALS market expected to grow to $1.04bn in 2029 driven by anticipated drug launches Posted in Pharma The late-stage ALS pipeline has several promising therapies that look to address some of the unmet needs in the market. Pipeline strategies have focused on bringing first-in-class treatments to the market with the hope that they can at least extend patient survival, and, at best, have neuroprotective properties. This has led to a variety of different therapeutic classes populating the late-stage pipeline: protein kinase inhibitors, heat shock protein co-inducers, stem cell therapies,...